Cargando…
Evolution and structure of clinically relevant gene fusions in multiple myeloma
Multiple myeloma is a plasma cell blood cancer with frequent chromosomal translocations leading to gene fusions. To determine the clinical relevance of fusion events, we detect gene fusions from a cohort of 742 patients from the Multiple Myeloma Research Foundation CoMMpass Study. Patients with mult...
Autores principales: | Foltz, Steven M., Gao, Qingsong, Yoon, Christopher J., Sun, Hua, Yao, Lijun, Li, Yize, Jayasinghe, Reyka G., Cao, Song, King, Justin, Kohnen, Daniel R., Fiala, Mark A., Ding, Li, Vij, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260243/ https://www.ncbi.nlm.nih.gov/pubmed/32471990 http://dx.doi.org/10.1038/s41467-020-16434-y |
Ejemplares similares
-
Co-evolution of tumor and immune cells during progression of multiple myeloma
por: Liu, Ruiyang, et al.
Publicado: (2021) -
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
por: Gao, Qingsong, et al.
Publicado: (2018) -
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
por: Yao, Lijun, et al.
Publicado: (2023) -
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
por: Muz, Barbara, et al.
Publicado: (2019) -
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
por: Sun, Jennifer, et al.
Publicado: (2020)